drugset / Trial / NCT02900469
Presurgical Trial of Denosumab in Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether one dose of denosumab can lead to changes in the tumor, which may decrease the ability of tumor to spread.
Timeline
- Start
- 2016-10
- Primary completion
- 2019-12-03
- Completion
- 2020-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denosumab | Monoclonal antibody | 120 mg | Subcutaneous |